Ozempic’s rise from diabetes treatment to cultural phenomenon has collided with a darker storyline: a growing wave of ...
Nearly 7% of people living with diabetes develop diabetic macular edema, a serious eye condition that can lead to vision loss, according to the Cleveland Clinic. Treatment can be costly, with the ...
May 28 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...
What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...
Global Ophthalmology Drugs Market OutlookThe global ophthalmology drugs market is forecasted to expand at a CAGR of nearly 8% over the next several years, driven by the rising burden of vision ...
“An oral drug that improves vision in DME [diabetic macular edema] would be a game changer because it would be more convenient for patients than frequent, often monthly, injections into the eye,” said ...
Aflibercept is used to treat certain serious eye conditions (such as macular edema/degeneration, diabetic retinopathy, retinopathy of prematurity). This medication can help preserve vision and prevent ...
Researchers at Science Tokyo developed an mRNA vaccine that suppressed abnormal retinal blood vessel growth in mouse models. The vaccine can be administered intramuscularly and showed effectiveness ...